塞栓療法市場 - 2031 年の成長予測、統計および事実

  • Report Code : TIPRE00006432
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 255
Buy Now

塞栓療法市場は、2021 年の 33 億 4,149 万米ドルから 2028 年までに 57 億 5,828 万米ドルに成長すると予想されています。 2022 年から 2028 年にかけて 8.1% の CAGR で成長すると推定されています。     

塞栓療法は、血管造影カテーテルを使用してバルーン、血栓、コイル、またはジェルフォームを導入することによる動脈の閉塞です。カテーテルは、出血性潰瘍、閉鎖瘻または動静脈奇形の治療、臓器の血管切除、血管欠損、または手術不能な出血の制御のために、バルーンまたは異物を埋め込むことによって血管を遮断するのに役立ちます。塞栓療法は、手術中に腫瘍に向かう血流やその周囲の血流を止めるためにも使用されます。

塞栓療法市場は、製品、疾患の適応症、処置のエンドユーザー、および地理に分割されています。地理的には、市場は北米、ヨーロッパ、アジア太平洋、中東、およびアジア太平洋に大きく分類されます。アフリカ、そして南と南。中米。このレポートは、市場動向や市場動向などのパラメーターに重点を置いた市場の洞察と詳細な分析、および世界をリードする市場プレーヤーの競争分析を提供します。

戦略的洞察

< h3>塞栓療法市場で有利な地域

市場洞察

低侵襲手術に対する患者の嗜好の高まりが塞栓療法市場を押し上げる

低侵襲手術は、術後の痛みが少なく、術後合併症が少なく、入院期間が短く、回復時間が早いため、患者がこのような手術を好む傾向が高まっています。非侵襲性または低侵襲性の治療法は、早期乳がん患者の手術に代わる方法として開発されています。たとえば、TACE としても知られる経動脈化学塞栓術は、肝細胞癌の治療に通常使用される低侵襲手術です。 TACE は無症候性で切除不能な肝がん患者を対象としています。 TACE を使用すると、腫瘍のサイズを縮小し、患者を肝移植の対象にすることができます。これは、以前に適用されていた経カテーテル動脈塞栓術 (TAE) と呼ばれる技術から進化したものと考えられています。

前立腺動脈塞栓術 (PAE) も、下部尿路症状に対する選択的外来技術として実施される低侵襲療法です。 (LUTS) 前立腺肥大症 (BPH) に続発するもの。 PAEで治療される患者の数は近年増加しています。このように、低侵襲処置に対する嗜好の高まりが塞栓療法市場の成長を促進しています。

製品インサイト

製品に基づいて、塞栓療法市場は塞栓剤と補助装置に二分されます。塞栓剤はさらに、ミクロスフェア、液体塞栓剤、塞栓コイル、塞栓プラグシステム、取り外し可能なバルーンなどにサブセグメント化されます。サポート デバイスは、さらにマイクロカテーテルとガイドワイヤにサブセグメント化されます。塞栓剤セグメントは、2021 年に最大の市場シェアを保持します。さらに、同じセグメントは、予測期間中に最高の CAGR を記録すると予想されます。塞栓剤セグメントの成長の主な推進要因は、さまざまな放射線治療処置における塞栓剤の使用の増加と、塞栓剤の進歩です。

塞栓療法市場、製品別 – 2022 年と 2028 年

疾患適応症に関する洞察

疾患適応症に基づいて、塞栓療法市場はがん、末梢血管疾患、神経疾患、泌尿器科および腎臓科に分類されます。病気、胃腸障害など。がんはさらに肝臓がん、腎臓がんなどに分類されます。がんセグメントは、2021年に最大の市場シェアを握ると見込まれています。さらに、同セグメントは2022年から2028年にかけて最速のCAGRを記録すると予想されています。がんセグメントの成長の主な原動力は、世界中でがんの発生率が増加していることです。

疾患適応に関する洞察

塞栓療法市場は、疾患適応に基づいて、経カテーテル動脈塞栓術 (TAE)、経カテーテル動脈放射線塞栓術 (TARE)/選択的内部放射線治療 (SIRT)、経動脈化学塞栓術(TACE)。経カテーテル動脈塞栓術(TAE)セグメントは、2021 年に最大の市場シェアを保持します。さらに、同じセグメントは 2022 年から 2028 年にかけて最速の CAGR を記録すると予想されます。経カテーテル動脈塞栓術(TAE)分野の成長を促進する主な要因は、高齢者による低侵襲手術に対する嗜好の高まり、慢性疾患の有病率の増加、および高齢者人口の急速な増加です。

エンドユーザーに関する洞察

エンドユーザーに基づいて、塞栓療法市場は病院と医療機関に分類されます。クリニック、外来手術センター、その他のエンドユーザー。 2021年、病院と病院は、クリニック部門が市場で最大のシェアを握る可能性が高い。さらに、同じセグメントは 2022 年から 2028 年にかけて最高の CAGR を記録すると予想されています。クリニック分野では、低侵襲外科手術(血管、泌尿器科、神経科を含む)の採用の増加、がんなどのさまざまな病気の治療のための病院への患者数の増加、これらの施設で行われる塞栓術の数の増加、医療機器の採用の増加が挙げられます。先進的かつ最先端の塞栓療法装置により、大病院、小規模診療所、救命救急病棟で複雑な処置を正確に実行できます。

製品の発売や承認などの有機的な開発は、塞栓療法市場の企業によって広く採用されている戦略です。 。最近の主要な市場動向のいくつかを以下に示します。

  • 2022 年 4 月、ボストン サイエンティフィック コーポレーションは 510(k) ) 末梢血管系の血流を妨げたり減少させたりすることを目的としたEMBOLDファイバー製取り外し可能コイルに対する米国食品医薬品局(FDA)からの認可。 Boston Scientific のインターベンショナル腫瘍学のポートフォリオに新たに追加された EMBOLD ファイバーコイルは、1 つ以上の血管を遮断して血流を遮断または減少させることを目的とした低侵襲治療である、さまざまな塞栓術で使用するために設計されました。
  • 2021年9月、アボットは末梢血栓を除去するために設計された低侵襲の機械的吸引血栓除去システムを備えた商用段階の医療機器会社であるウォーク・バスキュラーLLCを買収したと発表した。 Walk Vascular の末梢血栓除去システムは、アボットの既存の血管内製品ポートフォリオに組み込まれる予定です。

会社概要

  • アボット
  • ボストン サイエンティフィック コーポレーション< /li>
  • クック メディカル LLC
  • ジョンソン&amp;ジョンソン
  • メドトロニック
  • アカンディスGmbH
  • SSEM Mthembu Medical (Pty) Ltd
  • Balt USA LLC
  • ストライカー
  • ゲルベ合同会社
  • テルモ株式会社
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is embolotherapy?

Embolotherapy is an occlusion of arteries by introducing balloons, blood clots, coils or gel foam using an angiographic catheter. The catheter aids to block a blood vessel by implanting balloon or any foreign body, in order to treat bleeding ulcer, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defect or for control of inoperable hemorrhage. Embolotherapy is also used to stop blood flow towards and around a tumor during surgery.

What are the driving factors for the global embolotherapy market worldwide?

The factors driving the growth of the embolotherapy market are rising incidence of cancer cases, rising patient preference for minimally invasive procedures, and increasing incidence of hypertension, obesity, smoking, and alcoholism.

What are the restraining factors for the global embolotherapy market worldwide?

The availability of other alternative therapies, and the high cost of embolotherapy are expected to restrict the embolotherapy market growth during the forecast period.

Who are the major players in the embolotherapy market across the globe?

The embolotherapy market majorly consists of the players, such as as Abbott Laboratories, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson Consumer Inc., Medtronic, Acandis GmbH, Terumo Corporation, Balt USA LLC, Stryker Corporation, and Guerbet LLC, among others.

Which segment is dominating the embolotherapy market?

The global embolotherapy market based on product is bifurcated into embolic agents and support devices. The embolic agents is further sub-segmented into microsphere, liquid embolics agents, embolic coils, embolic plug systems, detachable balloons, and others. The support devices is further sub-segmented into microcatheters, and guidewires. The embolic agents segment is likely to hold the largest market share in 2021. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period

Which region is dominating the embolotherapy market?

The global embolotherapy market based on regions is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In 2021, the North American area held the largest market share. However, the Asia Pacific region is estimated to grow at the fastest CAGR of 8.5% during the forecast period

The List of Companies - Embolotherapy Market

  1. Abbott Laboratories           
  2. Boston Scientific Corporation         
  3. Cook Medical LLC                
  4. Johnson & Johnson Consumer Inc                
  5. Medtronic              
  6. Acandis GmbH     
  7. Terumo Corporation          
  8. Balt USA LLC          
  9. Stryker Corporation           
  10. Guerbet LLC.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports